Clinical practice guideline on diagnosis and treatment of hyponatraemia (Q22241512)

2

Raymond

Vanholder

1 reference

8 February 2023

B. Allolio

3

Bruno

Allolio

1 reference

8 February 2023

D. Annane

4

Djillali

Annane

1 reference

8 February 2023

S. Ball

5

Steve

Ball

1 reference

8 February 2023

D. Bichet

6

Daniel

Bichet

1 reference

8 February 2023

G. Decaux

7

Guy

Decaux

1 reference

8 February 2023

W. Fenske

8

Wiebke

Fenske

1 reference

8 February 2023

E. Hoorn

9

Ewout J

Hoorn

1 reference

8 February 2023

C. Ichai

10

Carole

Ichai

1 reference

8 February 2023

M. Joannidis

11

Michael

Joannidis

1 reference

8 February 2023

A. Soupart

12

Alain

Soupart

1 reference

8 February 2023

R. Zietse

13

Robert

Zietse

1 reference

8 February 2023

M. Haller

14

Maria

Haller

1 reference

8 February 2023

S. van der Veer

15

Sabine

van der Veer

1 reference

8 February 2023

W. Van Biesen

16

Wim

Van Biesen

1 reference

8 February 2023

E. Nagler

17

Evi

European Journal of Endocrinology

Nagler

1 reference

8 February 2023

language of work or name

English

0 references

publication date

25 February 2014

0 references

published in

0 references

volume

170

0 references

issue

3

0 references

page(s)

G1-G47

0 references

cites work

Hyponatremia, hyposmolality, and hypotonicity: tables and fables

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Impact of hospital-associated hyponatremia on selected outcomes.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The rational clinical examination. Is this patient hypovolemic?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Serious hyponatremia in patients with cancer: management with demeclocycline

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Efficacy of clozapine in a non-schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Mild hyponatremia as a risk factor for fractures: The rotterdam study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The use of demeclocycline in the treatment of patients with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome).

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

[Pseudohyponatremia in multiple myeloma (author's transl)]

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Beyond semantics: defining hyponatremia in secondary adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Incidence and prognosis of dysnatremias present on ICU admission

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Tonicity balance, and not electrolyte-free water calculations, more accurately guides therapy for acute changes in natremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Extrapontine myelinolysis with parkinsonism after rapid correction of hyponatremia: high cerebrospinal fluid level of homovanillic acid and successful dopaminergic treatment

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Central pontine and extrapontine myelinolysis despite careful correction of hyponatremia: clinical and neuropathological findings of a case.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Case seminar: a young female with acute hyponatremia and a sellar mass.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

(99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Rapid correction of severe hyponatremia with intravenous hypertonic saline solution.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Clinical assessment of extracellular fluid volume in hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Management of severe hyponatremia: rapid or slow correction?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Demeclocycline improves hyponatremia in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Treatment of psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome) using lithium and phenytoin

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia-hyponatremia in chronically psychotic patients.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Vasopressin V2 Receptor Blockade With Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Whole-body volume regulation and escape from antidiuresis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Mortality after hospitalization with mild, moderate, and severe hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Electrolyte disorders in community subjects: prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

[Extrapontine myelinolysis after correction of hyponatremia]

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Severe hyponatraemia and central pontine myelinolysis: be careful with other factors!

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

[Centropontine myelinolysis and extrapontine myelinolysis complicating the quick correction of a hyponatremia]

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Quantitative treatment of the hyponatremia of cirrhosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

GRADE guidelines: 3. Rating the quality of evidence

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Biochemical and etiological characteristics of acute hyponatremia in the emergency department

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Direct ion-selective electrode method is useful in diagnosis of pseudohyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

"Man-in-the-barrel" syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Klüver Bucy syndrome, unusual consequence of excessively rapid correction of severe hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The molecular and cellular identity of peripheral osmoreceptors.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The treatment of hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Epidemiology of hyponatremia.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia: evaluating the correction factor for hyperglycemia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyperammonemia after transurethral resection of the prostate: a report of 2 cases

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

https://api.crossref.org/works/10.1530%2FEJE-13-1020

1 reference

7 January 2021

Beer potomania: an unusual cause of symptomatic hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Posttransurethral prostatic resection hyponatremic syndrome: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Posterior pituitary function in health and disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Evaluation and management of hypo-osmolality in hospitalized patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Disorders of body water homeostasis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Central pontine myelinolysis: sequele of hyponatremia during transcervical resection of endometrium

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Brain dehydration and neurologic deterioration after rapid correction of hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Neurological and neuropathological sequelae of correction of chronic hyponatremia.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Milky plasma, diabetes, and severe hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

https://api.crossref.org/works/10.1530%2FEJE-13-1020

1 reference

7 January 2021

An N-terminal variant of Trpv1 channel is required for osmosensory transduction

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Central mechanisms of osmosensation and systemic osmoregulation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Extra pontine myelinolysis in a tetraplegic patient: case report

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Addison's disease in Africa--a teaching hospital experience

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

https://api.crossref.org/works/10.1530%2FEJE-13-1020

1 reference

7 January 2021

Peritoneal dialysis: new developments and new problems

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

"Beer potomania" in non-beer drinkers: effect of low dietary solute intake.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Contrast-induced translocational hyponatremia and hyperkalemia in advanced kidney disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

A review of drug-induced hyponatremia.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia and mortality: moving beyond associations

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Parkinsonism after correction of hyponatremia with radiological central pontine myelinolysis and changes in the basal ganglia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Superiority of Demeclocycline over Lithium in the Treatment of Chronic Syndrome of Inappropriate Secretion of Antidiuretic Hormone

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Demeclocycline-induced phosphate diabetes in patients with inappropriate secretion of antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2)

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Intravenous immune globulin and pseudohyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

https://api.crossref.org/works/10.1530%2FEJE-13-1020

1 reference

7 January 2021

Clinical practice. The syndrome of inappropriate antidiuresis.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Clinical problem-solving. Mind the gap

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Nephrogenic syndrome of inappropriate antidiuresis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia and mortality among patients on the liver-transplant waiting list

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Alternatives to hospital care

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Treating the syndrome of inappropriate ADH secretion with isotonic saline

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Solute loss plays a major role in polydipsia-related hyponatraemia of both water drinkers and beer drinkers

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Mild hyponatremia and risk of fracture in the ambulatory elderly

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Osmotic demyelination syndrome after correction of chronic hyponatremia with normal saline.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Deleterious effect of prolonged sodium administration and fluid restriction after partial correction of severe hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Fluid restriction does not improve the outcome of acute meningitis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Pseudohyponatremia in multiple myeloma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Treating hyponatremia: why haste makes waste

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Cisplatin-induced renal salt wasting syndrome

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Ocular motor and imaging abnormalities of midbrain dysfunction in osmotic demyelination syndrome.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Osmotic demyelination syndrome following rapid correction of hyponatraemia.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Characteristics and mortality of severe hyponatraemia--a hospital-based study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Novel risk factors for hospital-acquired hyponatraemia: a matched case-control study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Asking the right question and finding the right answers.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatraemia and central pontine myelinolysis after elective colonoscopy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Extrapontine myelinolysis after surgical removal of a pituitary tumour

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Treatment of hyponatraemic seizures with intravenous 29.2% saline.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatraemia and death or permanent brain damage in healthy children

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Lesson of the week: Acute hyponatraemia in children admitted to hospital: retrospective analysis of factors contributing to its development and resolution

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Misinterpretation of serum cortisol in a patient with hyponatraemia.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Osmotic demyelination syndrome

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Disorders of sodium balance: hypothyroidism and hyponatraemia: an old wives' tale?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Going from evidence to recommendations

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Possible case of peripheral osmotic demyelination syndrome

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

A trident in the brain, central pontine myelinolysis.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Demeclocycline in the treatment of the syndrome of inappropriate antidiuretic hormone release: with measurement of plasma ADH

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Lack of efficacy of phenytoin in the syndrome of inappropriate anti-diuretic hormone secretion of neurological origin

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Demeclocycline in the treatment of the syndrome of inappropriate secretion of antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Best cases from the AFIP: osmotic demyelination syndrome.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Neuropsychological findings of extrapontine myelinolysis without central pontine myelinolysis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

[Confusional syndrome in a patient with severe hyponatremia]

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia revisited: translating physiology to practice

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Effect of Demeclocycline on Renal Function and Urinary Prostaglandin E 2 and Kallikrein in Hyponatremic Cirrhotics

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Demeclocycline-induced phosphate diabetes in a patient with inappropriate ADH secretion and systemic sarcoidosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Osmotic myelinolysis with malignant cerebellar edema occurring after DDAVP-induced hyponatremia in a child

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Central pontine myelinolysis despite slow sodium rise in a case of severe community-acquired hyponatraemia.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate--a retrospective study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Treatment of euvolemic hyponatremia in the intensive care unit by urea

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Copeptin in the differential diagnosis of hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

The Interaction of Blood Osmolality and Blood Volume in Regulating Plasma Vasopressin in Man

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Pontine/extrapontine myelinolysis occurring in the setting of an eating disorder

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Cortical MRI findings associated with rapid correction of hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Sodium measurement: effects of differing sampling and analytical methods

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Central pontine myelinolysis following 'optimal' rate of correction of hyponatraemia with a good clinical outcome.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Severe hyponatremia with high urine sodium and osmolality

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

AGREE II: advancing guideline development, reporting and evaluation in health care

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Amplification of transducer gain by angiotensin II-mediated enhancement of cortical actin density in osmosensory neurons.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Influence of low- and high-pressure baroreflexes on vasopressin release in humans

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Central pontine myelinolysis in a previously healthy 4-year-old child with acute rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Pontine and extrapontine osmotic myelinolysis after the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Adaptive responses to sustained volume expansion in hyponatraemic rats

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Body fluid dynamics: back to the future

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Amelioration of extrapontine myelinolysis and reversible parkinsonism in a patient with asymptomatic hypopituitarism

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hypertonic saline for hyponatremia: risk of inadvertent overcorrection

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia and mortality: how innocent is the bystander?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Late occurrence of severe hyponatremia followed by extrapontine osmotic demyelination syndrome after successful conservative management of postpartum hemorrhage due to placenta accreta by uterine artery embolization

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Central pontine myelinolysis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: A prospective observational trial

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Postoperative hyponatremic encephalopathy in menstruant women

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Maltose-induced hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Myelinolysis after correction of hyponatremia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Hyponatremia in primary myxedema

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021

Renal Failure Associated with Demeclocycline in Cirrhosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-13-1020

7 January 2021